EP1866338
Mótefni gegn CD38 sem meðferð við mergæxli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.3.2006EP published:
21.9.2016EP application number:
06722861.9
EP translation filed:
19.12.2016Grant published:
15.1.2017EPO information:
European Patent Register
Max expiry date:
22.3.2026Expiry date:
22.3.2026
Title:
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
Timeline
Today
23.3.2006EP application
21.9.2016EP Publication
19.12.2016Translation submitted
15.1.2017Registration published
22.3.2026Expires
Owner
Name:
Genmab A/SAddress:
Carl Jacobsens Vej 30, 2500, Valby, DK
Inventor
Name:
WEERS, Michel deAddress:
NL-3991 WR Houten, NL
Name:
GRAUS, YvoAddress:
NL-3984 PR Odijk, NL
Name:
OPRINS, JudithAddress:
NL-3521 TK Utrecht, NL
Name:
PARREN, PaulAddress:
NL-3984 PR Odijk, NL
Name:
WINKEL, Jan van deAddress:
NL-3707 CK Zeist, NL
Name:
VUGT, Martine vanAddress:
KR Houten, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
200500429Date:
23.3.2005Country:
DK
Number:
667579 PDate:
1.4.2005Country:
US
Number:
696163 PDate:
1.7.2005Country:
US
Number:
728561 PDate:
20.10.2005Country:
US
Classification
Categories:
C07K 16/28, C07K 14/705, A61K 39/395, G01N 33/50, C12N 5/10, A61P 35/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 10.2.2017
Expires: 22.3.2018
Payer: Árnason Faktor
Number: 13
Paid: 8.2.2018
Expires: 22.3.2019
Payer: Árnason Faktor
Number: 14
Paid: 7.2.2019
Expires: 22.3.2020
Payer: Árnason Faktor
Number: 15
Paid: 18.2.2020
Expires: 22.3.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 8.2.2021
Expires: 22.3.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 8.2.2022
Expires: 22.3.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 8.2.2023
Expires: 22.3.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 14.2.2024
Expires: 22.3.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 14.2.2025
Expires: 22.3.2026
Payer: Árnason Faktor ehf.